Research resource: Global identification of estrogen receptor β target genes in triple negative breast cancer cells

Molecular Endocrinology

Volumn 27, Issue 10, 2013, Pages 1762-1775

  Shanle, Erin K ^a,b   Zhao, Zibo ^b   Hawse, John ^c   Wisinski, Kari ^d   Keles, Sunduz ^e   Yuan, Ming ^f   Xu, Wei ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; PROGESTERONE RECEPTOR; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SEQUENCE; TRIPLE NEGATIVE BREAST CANCER; TUMOR REGRESSION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSCRIPTOME; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84884744372     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1164     Document Type: Article

References (44)

1. Skliris GP, Leygue E, Curtis-Snell L, Watson PH, Murphy LC. Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours. Br J Cancer. 2006;95(5):616-626.
2. Honma N, Horii R, Iwase T, et al. Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol. 2008;26(22):3727-3734.
3. Marotti JD, Collins LC, Hu R, Tamimi RM. Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol. 2010; 23(2):197-204.
4. Yan M, Rayoo M, Takano EA, kConFab Investigators, Fox SB. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers. Breast Cancer Res Treat. 2011;126(2):395-405.
5. Leung Y-K, Mak P, Hassan S, Ho S-M. Estrogen receptor (ER)-b isoforms: a key to understanding ER-β signaling. Proc Natl Acad Sci USA. 2006;103(35):13162-13167.
6. Peng B, Lu B, Leygue E, Murphy L. Putative functional characteristics of human estrogen receptor-β isoforms. J Mol Endocrinol. 2003;30(1):13-29.
7. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 2004;64(1):423-428.
8. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA. 2004;101(6):1566-1571.
9. Murphy LC, Peng B, Lewis A, et al. Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol. 2005;34(2): 553-566.
10. Hartman J, Lindberg K, Morani A, Inzunza J, Ström A, Gustafsson JA. Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 2006;66(23):11207-11213.
11. Hodges-Gallagher L, Valentine CD, El Bader S, Kushner PJ. Estrogen receptor β increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res Treat. 2008;109(2):241-250.
12. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F. ER β inhibits proliferation and invasion of breast cancer cells. Endocrinology. 2001;142(9):4120-4130.
13. Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O. Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Breast Cancer Res Treat. 2008;110(3):507-520.
14. Chen L, Qiu J, Yang C, et al. Identification of a novel estrogen receptor β1 binding partner, inhibitor of differentiation-1, and role of ERβ1 in human breast cancer cells. Cancer Lett. 2009;278(2): 210-219.
15. Secreto FJ, Monroe DG, Dutta S, Ingle JN, Spelsberg TC. Estrogen receptor α/β isoforms, but not βcx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. J Cell Biochem. 2007;101(5):1125-1147.
16. Hartman J, Ström A, Gustafsson JA. Estrogen receptor β in breast cancer-diagnostic and therapeutic implications. Steroids. 2009; 74(8):635-641.
17. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) α or ERβ in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology. 2004;145(7):3473-3486.
18. Shanle EK, Hawse JR, Xu W. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands. Biochem Pharmacol. 2011;82(12):1940-1949.
19. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518-524.
20. Li B, Ruotti V, Stewart RM, Thomson JA, Dewey CN. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics. 2010;26(4):493-500.
21. Faulkner GJ, Forrest AR, Chalk AM, et al. A rescue strategy for multimapping short sequence tags refines surveys of transcriptional activity by CAGE. Genomics. 2008;91(3):281-288.
22. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):621-628.
23. Taub MLD, Speed TP. Methods for allocating ambiguous shortreads. Comm Inform Syst. 2010;10(2):69-82.
24. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.
25. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106.
26. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B (Method). 1995;57:289-300.
28. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100(16):9440-9445.
29. Harris HA, Albert LM, Leathurby Y, et al. Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology. 2003;144(10):4241-4249.
30. Grober OM, Mutarelli M, Giurato G, et al. Global analysis of estrogen receptor β binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor β for target gene regulation. BMC Genomics. 2011;12:36.
31. Cotrim CZ, Fabris V, Doria ML, et al. Estrogen receptor β growthinhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Oncogene. 2012;32(19):2390-2402.
32. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87(3): 905-931.
33. Cowley SM, Parker MG. A comparison of transcriptional activation by ERα and ERβ. J Steroid Biochem Mol Biol. 1999;69(1-6): 165-175.
34. Hall JM, McDonnell DP. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERβ transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999;140:5566-5578.
35. Tremblay A, Tremblay GB, Labrie F, Giguère V. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Molecular Cell. 1999;3(4): 513-519.
36. Vivar OI, Zhao X, Saunier EF, et al. Estrogen receptor β binds to and regulates three distinct classes of target genes. J Biol Chem. 285(29):22059-22066.
37. Zhao C, Putnik M, Gustafsson JA, Dahlman-Wright K. Microarray analysis of altered gene expression in ERβ-overexpressing HEK293 cells. Endocrine. 2009;36(2):224-232.
38. Ayyanan A, Civenni G, Ciarloni L, et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci USA. 2006; 103(10):3799-3804.
39. Green JL, La J, Yum KW, et al. Paracrine Wnt signaling both promotes and inhibits human breast tumor growth. Proc Natl Acad Sci USA. 2013;110(17):6991-6996.
40. Palmieri C, Saji S, Sakaguchi H, et al. The expression of oestrogen receptor (ER)-β and its variants, but not ERβ, in adult human mammary fibroblasts. J Mol Endocrinol. 2004;33(1):35-50.
41. Shah SP, Roth A, Goya R, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395-399.
42. Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750-2767.
43. Skliris GP, Lewis A, Emberley E, et al. Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Res Treat. 2007;104(1):75-85.
44. Roman-Blas JA, Castañeda S, Cutolo M, Herrero-Beaumont G. Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study. Arthritis Care Res (Hoboken). 2010;62(11):1588-1593.